Zhenhao Qi

Company: Daiichi Sankyo

Job title: Director, Global Companion Diagnostics Lead Global Companion Diagnostics Global Oncology R&D

Seminars:

Describing a Retrospective Approach: Liquid Biopsy CDx Development & Submission for HER2-mut NSCLC 5:00 pm

Elucidating how liquid biopsy tests allow NSCLC patients access to HER2 mutation results who otherwise would not be tested Describing the validation study design of Guardant360 CDx test in detection of HER2 mutation in plasma obtained from patients with NSCLC Raising challenges and solutions in retrospective CDx developmentRead more

day: Day One Track B PM 2